Navigation Links
NCPA Statement on 'Sense of Congress' Resolution Opposing FDA Restrictions on Estriol Usage
Date:5/7/2008

ALEXANDRIA, Va., May 7 /PRNewswire-USNewswire/ -- Yesterday H. Con. Res. 342 was introduced by Rep. Mike Ross (D-Ark.) and Jo Ann Emerson (R-Mo.) opposing the Food and Drug Administration's (FDA) decision to restrict Estriol (a form of Estrogen), a compounded hormone preparation used by women to alleviate the symptoms of menopause. The action was taken after the FDA sent letters to seven pharmacies in January asking them to cease and desist with the use of estriol. At this time, there is insufficient evidence substantiating the need for restriction. In response Bruce Roberts, RPh, executive vice president and CEO of the National Community Pharmacists Association (NCPA), issued the following statement:

"Estriol helps women manage the menopause process and has been proven safe and effective. FDA's decision is not predicated on evidence, therefore questioning their interference in the states' jurisdiction over drug compounding. The National Community Pharmacists Association commends Representatives Mike Ross and Jo Ann Emerson for their 'Sense of Congress' resolution urging the FDA to reconsider their restrictions on the use of Estriol."

NOTE: Representatives Tammy Baldwin (D-Wis.), Michael Burgess (R-Texas), John Carter (R-Texas), Sam Farr (D-Calif.), and Gabrielle Giffords (D-Ariz.) were also instrumental in bringing this much needed language to the House floor.

The National Community Pharmacists Association, founded in 1898, represents the nation's community pharmacists, including the owners of more than 23,000 pharmacies. The nation's independent pharmacies, independent pharmacy franchises, and independent chains dispense nearly half of the nation's retail prescription medicines. To learn more go to http://www.ncpanet.org.


'/>"/>
SOURCE National Community Pharmacists Association
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. A Statement from GlaxoSmithKline Consumer Healthcare on 2008 Update to the U.S. Public Health Service Guideline on Treating Tobacco Use and Dependence
2. Statement by UHW President Sal Rosselli on SEIU Threat to Sue UHW Leaders
3. Pelosi Statement on Cover the Uninsured Week
4. Medarex and Bristol-Myers Squibb Joint Statement on Submission Status of Ipilimumab
5. Statement by H.E. Jakaya Mrisho Kikwete, President of the United Republic of Tanzania, and Chairman of the African Union, in Response to UN-SG Call to Action on Malaria
6. AHIP Statement on Senate Passage of the Genetic Information Nondiscrimination Act
7. SEIU RN Dian Palmer Calls on AFL-CIO Head John Sweeney to Review Video From Dearborn Protest, Retract Statement Accepting CNA Distortions
8. CNA/NNOC Statement on Restraining Order Against SEIU: Threats, Harassment and Stalking of RNs Remain Out of Bounds
9. Statement: Congress Should Include the Physician Self-Referral Provision in the Farm Bill for Patients and Communities
10. Statement From Larry Minnix, President & CEO, American Association of Homes and Services for the Aging (AAHSA) on the Senate Special Committee on Aging Hearing, Caring for Our Seniors: How Can We Support the Frontlines?
11. Statement by SEIU International President Andy Stern Regarding CNA Temporary Restraining Order
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2009)...4 In response to breaking news of ...kson,s death, the American Society of Anesthesiolo...e American Society of Anesthesiologists (ASA), whi...nal anesthesia care, does not know the specific ci...owever, the ASA unequivocally maintains that Dipri...
(Date:7/3/2009)...ay thwart treatment-resistant strain, study finds ...-- Extreme drug-resistant tuberculosis might somed...arkinson,s disease, suggests a new study. , R...alifornia, San Diego, report in the July 3 issue o...vailable entacapone and tolcapone have the potenti...
(Date:7/3/2009)...July 3 /PRNewswire-Asia/ -- Sundia MediTech, a lea...D outsourcing company in Shanghai,China announce...or Vice,President of Chemistry Services. , ...crine Biosciences, a drug,discovery and developme...staff,scientist to Senior Director of Medicinal C...
(Date:7/3/2009)... "This is an opportunity for you to ch... Diabetic Free pills, you will experience a notice... your blood sugar, cholesterol levels and blood pr...vitalized and your mind will finally be freed from...diabetes patient." , ...
Breaking Medicine News(10 mins):Health News:American Society of Anesthesiologists Releases Following Statement Related to Media Inquires Regarding Michael Jackson's Death 2Health News:New Weapons in Fight Against TB? 2Health News:Sundia MediTech Appoints Dr. Chen Chen as Senior VP of Chemistry 2Health News:Patients Suffering from Diabetes Now Have the Option to Suffer No More with Diabetic Free All Natural Medical Herbal Extracts Capsules 2Health News:Patients Suffering from Diabetes Now Have the Option to Suffer No More with Diabetic Free All Natural Medical Herbal Extracts Capsules 3Health News:Patients Suffering from Diabetes Now Have the Option to Suffer No More with Diabetic Free All Natural Medical Herbal Extracts Capsules 4
...ice Guidelines (CPG) has recommended that waist ci... It also added that a national surveillance system...long with height and weight. This represents a la...irst country in the world to produce comprehensive...
...dy with dietary supplements, without any proof of ...is spent by Americans annually on dietary suppleme... at bay and extend life. Research conducted on V...f enhancing cardiovascular health. Ginkgo biloba, ...
...rjee was discharged from the Army Hospital here //...in a road accident in West Bengal. A team of me...uesday morning and was satisfied with his fast pac... investigations and scans on Mukherjee, including ...
...east 41 lives in Jakarta, capital of Indonesia. Th...een affected// by it. Governor Sutiyoso said th...ly since January, with a total of 11,094 people in...ported. By comparison, the whole of 2006 saw 24...
Other Medicine News:Health News:New Guidelines to Address Growing Obesity Epidemic 2Health News:New Guidelines to Address Growing Obesity Epidemic 3
(Date:6/29/2009)...ire/ -- Vantia Therapeutics, an,emerging pharmace...ugs,targeting large, underserved medical markets,...ical trial of its lead development compound VA1064...483 was successful in producing a,predictable and...termined by,increased osmolality and decreased ur...
(Date:6/28/2009)...29 Data presented,today, in Budap...ovel,once-daily anti-epileptic Zebinix(R)* (esli...d sustained decrease in seizure frequency over the...extension of a pivotal Eslicarbazepine Acetate,ph...Congress for Epilepsy in,Budapest, Hungary. Patie...
(Date:6/26/2009)..., June 27, 2009 Takeda Pharmaceuti...t Takeda Global Research & Development Center,...ary received on June 26 (U.S. time) a complete res...ation (FDA) regarding the Company,s New Drug Appli...l peptidase IV (DPP-4) inhibitor under investigati...
(Date:6/26/2009)... Cancer Recurrence Test MammaPrint,Included in In...tions" issued,on 23 Jun 2009 12:00 GMT, by Agendi...he subheadline was missing from the release as inc...rrected release follows: , , /PRNewswire...est MammaPrint Included in,International St. Gall...
Breaking Medicine Technology:Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia 2Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia 3Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 2Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 3Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 4Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 5Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 6Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 7Takeda Receives FDA Complete Response Letter for Alogliptin, an Investigational Treatment for Type 2 Diabetes 2/C O R R E C T I O N -- Agendia B.V./ 2/C O R R E C T I O N -- Agendia B.V./ 3Life Brokerage Partners Adds New Insurance Carriers 9437 1Life Brokerage Partners Adds New Insurance Carriers 9437 2Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance 28TM 29 9434 1Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance 28TM 29 9434 2Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance 28TM 29 9434 3Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance 28TM 29 9434 4Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance 28TM 29 9434 5Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance 28TM 29 9434 6Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance 28TM 29 9434 7UM Sylvester Offers Community the Gift of Well Being 9432 1UM Sylvester Offers Community the Gift of Well Being 9432 2UM Sylvester Offers Community the Gift of Well Being 9432 3Personal Safes Market to Top 24308 Million by 2011 1854 1Personal Safes Market to Top 24308 Million by 2011 1854 2
... 2007 /PRNewswire-FirstCall/ --,Advanced Magnetics...ase III multi- center clinical studies of ferumoxy... will be presented during,the National Kidney Foun...place April 10th through 14th in Orlando, Florida....be presented on,Wednesday, April 11, 2007 at appro...
...wed Complete Response or Reduction of,Lesion Size ... 05, 2007 /PRNewswire-FirstCall/ - Nventa,Biopharm...ation of,positive results from a clinical trial ex...spE7, an investigational therapeutic,vaccine for h...en,with the highest grade of cervical dysplasia (C...
Other Medicine Technology:Advanced Magnetics Announces Presentation of Ferumoxytol Data at,the National Kidney Foundation 2007 Spring Clinical Meetings 2Advanced Magnetics Announces Presentation of Ferumoxytol Data at,the National Kidney Foundation 2007 Spring Clinical Meetings 3Advanced Magnetics Announces Presentation of Ferumoxytol Data at,the National Kidney Foundation 2007 Spring Clinical Meetings 4Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 2Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 3Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 4Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 5Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 6
Cocoon Disposable Patient Warming Blankets are specially designed to prevent hypothermia and maintain normothermia in your patients. The soft warm coloured material is strong and resists tearing and
This blanket gently surrounds the child with temperature-controlled air. Use one or both of the enclosed clear plastic drapes to keep warmed air near the skin.
2-ply material consisting of polyethylene film inner layer and non-woven outer layers.
This unique blanket is designed to be used for many surgical procedures, including but not limited to: laminectomies, spinal procedures, abdominal procedures, and transplants.
Medicine Products: